These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
155 related articles for article (PubMed ID: 35799446)
1. The uptake and utility of genetic testing and genetic counseling for hypertrophic cardiomyopathy-A systematic review and meta-analysis. Cirino AL; Harris SL; Murad AM; Hansen B; Malinowski J; Natoli JL; Kelly MA; Christian S J Genet Couns; 2022 Dec; 31(6):1290-1305. PubMed ID: 35799446 [TBL] [Abstract][Full Text] [Related]
2. Factors Associated with Uptake of Genetics Services for Hypertrophic Cardiomyopathy. Khouzam A; Kwan A; Baxter S; Bernstein JA J Genet Couns; 2015 Oct; 24(5):797-809. PubMed ID: 25566741 [TBL] [Abstract][Full Text] [Related]
3. The uptake of family screening in hypertrophic cardiomyopathy and an online video intervention to facilitate family communication. Harris S; Cirino AL; Carr CW; Tafessu HM; Parmar S; Greenberg JO; Szent-Gyorgyi LE; Ghazinouri R; Glowny MG; McNeil K; Kaynor EF; Neumann C; Seidman CE; MacRae CA; Ho CY; Lakdawala NK Mol Genet Genomic Med; 2019 Nov; 7(11):e940. PubMed ID: 31482667 [TBL] [Abstract][Full Text] [Related]
4. Outcomes of Contemporary Family Screening in Hypertrophic Cardiomyopathy. van Velzen HG; Schinkel AFL; Baart SJ; Oldenburg RA; Frohn-Mulder IME; van Slegtenhorst MA; Michels M Circ Genom Precis Med; 2018 Apr; 11(4):e001896. PubMed ID: 29661763 [TBL] [Abstract][Full Text] [Related]
5. Psychosocial Impact of a Positive Gene Result for Asymptomatic Relatives at Risk of Hypertrophic Cardiomyopathy. Bonner C; Spinks C; Semsarian C; Barratt A; Ingles J; McCaffery K J Genet Couns; 2018 Sep; 27(5):1040-1048. PubMed ID: 29468337 [TBL] [Abstract][Full Text] [Related]
6. Examining the Psychosocial Impact of Genetic Testing for Cardiomyopathies. Wynn J; Holland DT; Duong J; Ahimaz P; Chung WK J Genet Couns; 2018 Aug; 27(4):927-934. PubMed ID: 29243008 [TBL] [Abstract][Full Text] [Related]
7. Penetrance of hypertrophic cardiomyopathy in children and adolescents: a 12-year follow-up study of clinical screening and predictive genetic testing. Jensen MK; Havndrup O; Christiansen M; Andersen PS; Diness B; Axelsson A; Skovby F; Køber L; Bundgaard H Circulation; 2013 Jan; 127(1):48-54. PubMed ID: 23197161 [TBL] [Abstract][Full Text] [Related]
8. Uptake of genetic counselling and predictive DNA testing in hypertrophic cardiomyopathy. Christiaans I; Birnie E; Bonsel GJ; Wilde AA; van Langen IM Eur J Hum Genet; 2008 Oct; 16(10):1201-7. PubMed ID: 18478037 [TBL] [Abstract][Full Text] [Related]
9. Genetic Testing in Hypertrophic Cardiomyopathy. Ireland CG; Ho CY Am J Cardiol; 2024 Feb; 212S():S4-S13. PubMed ID: 38368035 [TBL] [Abstract][Full Text] [Related]
10. Merits and pitfalls of genetic testing in a hypertrophic cardiomyopathy clinic. Arad M; Monserrat L; Haron-Khun S; Seidman JG; Seidman CE; Arbustini E; Glikson M; Freimark D Isr Med Assoc J; 2014 Nov; 16(11):707-13. PubMed ID: 25558701 [TBL] [Abstract][Full Text] [Related]
11. Clinical Characteristics and Long-Term Outcome of Hypertrophic Cardiomyopathy in Individuals With a MYBPC3 (Myosin-Binding Protein C) Founder Mutation. van Velzen HG; Schinkel AFL; Oldenburg RA; van Slegtenhorst MA; Frohn-Mulder IME; van der Velden J; Michels M Circ Cardiovasc Genet; 2017 Aug; 10(4):. PubMed ID: 28794111 [TBL] [Abstract][Full Text] [Related]
12. Diagnostic validity and clinical utility of genetic testing for hypertrophic cardiomyopathy: a systematic review and meta-analysis. Christian S; Cirino A; Hansen B; Harris S; Murad AM; Natoli JL; Malinowski J; Kelly MA Open Heart; 2022 Apr; 9(1):. PubMed ID: 35387861 [TBL] [Abstract][Full Text] [Related]
13. Uptake of cardiac screening and genetic testing among hypertrophic and dilated cardiomyopathy families. Miller EM; Wang Y; Ware SM J Genet Couns; 2013 Apr; 22(2):258-67. PubMed ID: 23054336 [TBL] [Abstract][Full Text] [Related]
14. Genetic counseling and cardiac care in predictively tested hypertrophic cardiomyopathy mutation carriers: the patients' perspective. Christiaans I; van Langen IM; Birnie E; Bonsel GJ; Wilde AA; Smets EM Am J Med Genet A; 2009 Jul; 149A(7):1444-51. PubMed ID: 19533783 [TBL] [Abstract][Full Text] [Related]
16. Genetic testing and cascade screening in pediatric long QT syndrome and hypertrophic cardiomyopathy. Knight LM; Miller E; Kovach J; Arscott P; von Alvensleben JC; Bradley D; Valdes SO; Ware SM; Meyers L; Travers CD; Campbell RM; Etheridge SP Heart Rhythm; 2020 Jan; 17(1):106-112. PubMed ID: 31229680 [TBL] [Abstract][Full Text] [Related]
17. Genetic testing impacts the utility of prospective familial screening in hypertrophic cardiomyopathy through identification of a nonfamilial subgroup. Ko C; Arscott P; Concannon M; Saberi S; Day SM; Yashar BM; Helms AS Genet Med; 2018 Jan; 20(1):69-75. PubMed ID: 28640247 [TBL] [Abstract][Full Text] [Related]
18. Genetic Testing and Counseling for Hypertrophic Cardiomyopathy. Cirino AL; Seidman CE; Ho CY Cardiol Clin; 2019 Feb; 37(1):35-43. PubMed ID: 30447714 [TBL] [Abstract][Full Text] [Related]
19. Results of comprehensive genetic testing in patients presenting to a multidisciplinary inherited heart disease clinic in India. Chockalingam P; Geetha TS; Nair S; Rajakumar N; Raja DC; Lokhandwala Y; Chaturvedi V; Selvaraj RJ; Ramasamy S; Sharda S; Sundar C; Anantharaman R Indian Heart J; 2024; 76(4):260-267. PubMed ID: 39009076 [TBL] [Abstract][Full Text] [Related]
20. Penetrance of Hypertrophic Cardiomyopathy in Sarcomere Protein Mutation Carriers. Lorenzini M; Norrish G; Field E; Ochoa JP; Cicerchia M; Akhtar MM; Syrris P; Lopes LR; Kaski JP; Elliott PM J Am Coll Cardiol; 2020 Aug; 76(5):550-559. PubMed ID: 32731933 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]